Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway. (2015). Clinics, 70(4), 250-256. https://doi.org/10.6061/clinics/2015(04)06